Role of antigastric autoantibodies in chronic Helicobacter pylori infection

Microscopy Research and Technique

Volumn 48, Issue 6, 2000, Pages 321-326

  Faller, Gerhard ^a   Kirchner, Thomas ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NONE

Author keywords

Antigastric autoantibodies; Autoimmunity; Gastritis; H,K ATPase; Helicobacter pylori

Indexed keywords

ANTIGASTRIC AUTOANTIBODY; ATPASES; AUTOANTIBODIES; AUTOIMMUNITY; BINDING PATTERN; GASTRITIS; H,K-ATPASE; HELICOBACTER PYLORI; HELICOBACTER PYLORI INFECTIONS; INFECTED PATIENTS;

AUTOANTIBODY; PARIETAL CELL ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC GASTRITIS; DISEASE ASSOCIATION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR MIMICRY; OUTCOMES RESEARCH; PATHOGENESIS; PRIORITY JOURNAL;

HELICOBACTER PYLORI;

EID: 0034653744     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0029(20000315)48:6<321::AID-JEMT2>3.0.CO;2-U     Document Type: Article

References (69)

1. Amano K, Hayashi S, Kubota T, Fujii N, Yokota S. 1997. Reactivities of Lewis antigen monoclonal antibodies with the lipopolysaccharides of Helicobacter pylori strains isolated from patients with gastroduodenal diseases in Japan. Clin Diagn Lab Immunol 4:540-544.
2. Appelmelk BJ, Simoons-Smit I, Negrini R, Moran AP, Aspinall GO, Forte JG, De Vries T, Quan H, Verboom T, Maaskant JJ, Ghiara P, Kuipers EJ, Bloemena E, Tadema TM, Townsend RR, Tyagarajan K, Crothers JM Jr, Monteiro MA, Savio A, De Graaff J. 1996. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun 64:2031-2040.
3. Appelmelk BJ, Negrini R, Moran AP, Kuipers EJ. 1997. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol 5:70-73.
4. Appelmelk BJ, Taller G, Claeys D, Kirchner T, Vandenbroucke-Grauls CM. 1998a. Bugs on trial: the case of Helicobacter pylori and autoimmunity. Immunol Today 19:296-299.
5. Appelmelk BJ, Straver S, Verboom T, Kuipers EJ, Claeys D, Faller G, Kirchner T, Negrini R, Krakowka S, De Pont JJHHM, Simoons-Smit I, Maaskant JJ, Vandenbroucke-Grauls CMJE. 1998b. Molecular mimicry between Helicobacter pylori and the host. In: Hunt RH, Tytgat GNJ, editors. Helicobacter pylori. Basic mechanisms to clinical cure 1998. Dordrecht: Kluwer Academic Publishers, p 33-42.
6. Atherton JC, Peek RM Jr, Tham KT, Cover TL, Blaser MJ. 1997. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112:92-99.
7. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, Brooks EG, Graham DY, Reyes VE, Ernst PB. 1998. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114:482-492.
8. Cariani G, Bonora G, Vandelli A, Mazzoleni G, Fontana G. 1991. Helicobacter pylori in autoimmune gastritis. Gastroenterology 101: 759.
9. Claeys D, Faller G, Appelmelk BJ, Negrini R, Kirchner T. 1998. The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 115:340-347.
10. Crabtree JE, Wyatt JI, Trejdosiewicz LK, Peichl P, Nichols PH, Ramsay N, Primrose JN, Lindley IJ. 1994. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol 47:61-66.
11. Czinn SJ, Nedrud JG. 1997. Immunopathology of Helicobacter pylori infection and disease. Springer Semin Immunopathol 18:495-513.
12. de Figueiredo Soares T, de Magalhaes Queiroz DM, Mendes EN, Rocha GA, Rocha Oliveira AM, Alvares Cabral MM, de Oliveira CA. 1998. The interrelationship between Helicobacter pylori vacuolating cytotoxin and gastric carcinoma. Am J Gastroenterol 93:1841-1847.
13. Dixon MF, Genta RM, Yardley JH, Correa P. 1996. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston, 1994. Am J Surg Pathol 20:1161-1181.
14. Eck M, Schmausser B, Haas R, Greiner A, Czub S, Muller-Hermelink HK. 1997. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 112:1482-1486.
15. Eidt S, Oberhuber G, Schneider A, Stolte M. 1996. The histopathological spectrum of type A gastritis. Pathol Res Pract 192:101-106.
16. Engstrand L, Scheynius A, Pahlson C, Grimelius L, Schwan A, Gustavsson S. 1989. Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun 57:827-832.
17. Ernst PB, Crowe SE, Reyes VE. 1997. How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterology 113:35-42.
18. Faisal MA, Russell RM, Samloff IM, Holt PR. 1990. Helicobacter pylori infection and atrophic gastritis in the elderly. Gastroenterology 99:1543-1544.
19. Faller G, Steininger H, Eck M, Hensen J, Hann EG, Kirchner T. 1996. Antigastric autoantibodies in Helicobacter pylori gastritis: prevalence, in-situ binding sites and clues for clinical relevance. Virchows Arch 427:483-486.
20. Faller G, Steininger H, Kranzlein J, Maul H, Kerkau T, Hensen J, Hahn EG, Kirchner T. 1997. Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut 41:619-623.
21. Faller G, Steininger H, Appelmelk B, Kirchner T. 1998a. Evidence of novel pathogenic pathways for the formation of antigastric autoantibodies in Helicobacter pylori gastritis. J Clin Pathol 51:244-245.
22. Faller G, Winter M, Steininger H, Konturek P, Konturek SJ, Kirchner T. 1998b. Antigastric autoantibodies and gastric secretory function in Helicobacter pylori-infected patients with duodenal ulcer and non-ulcer dyspepsia. Scand J Gastroenterol 33:276-282.
23. Faller G, Winter M, Steininger H, Lehn N, Meining A, Bayerdorffer E, Kirchner T. 1999. Decrease of antigastric autoantibodies in Helicobarter pylori gastritis after cure of infection. Pathol Res Pract 195:243-246.
24. Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno RA, Russi M, Quaranta S. 1989. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 27:225-226.
25. Fixa B, Malfertheiner P, Tuschy P, Komarkova O, Nozicka Z. 1995. Infekce Helicobacter pylori a zaludecni autoimunita - spolecne etiopatogeneticke mechanismy u chronicke gastridy. Ces. a Slov. Gastroen 49:147-152.
26. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, Sitas F. 1991. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 302:1302-1305.
27. Fox JG, Correa P, Taylor NS, Thompson N, Fontham E, Janney F, Sobhan M, Ruiz B, Hunter F. 1992. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol 87:1554-1560.
28. Graham DY, Genta RM, Graham DP, Crabtree JE. 1996. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol 49:829-832.
29. Guruge JL, Falk PG, Lorenz RG, Dans M, Wirth HP, Blaser MJ, Berg DE, Gordon JI. 1998. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci USA 95:3925-3930.
30. Haeberle HA, Kubin M, Bamford KB, Garofalo R, Graham DY, El-Zaatari F, Karttunen R, Crowe SE, Reyes VE, Ernst PB. 1997. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun 65:4229-4235.
31. Ito Y, Azuma T, Ito S, Miyaji H, Hirai M, Yamazaki Y, Sato F, Kato T, Kohli Y, Kuriyama M. 1997. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 35:1710-1714.
32. Karnes WJ, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, Walsh JH. 1991. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis [see comments]. Gastroenterology 101:167-174.
33. Karttunen R. 1991. Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures with Helicobacter pylori. Comparison of the responses of subjects with and without antibodies to H. pylori. Clin Exp Immunol 83:396-400.
34. Karttunen R, Andersson G, Poikonen K, Kosunen TU, Karttunen T, Juutinen K, Niemela S. 1990. Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin Exp Immunol 82:485-488.
35. Kelleher D, Windle H, Fan X. 1997. Human immune responses to Helicobacter pylori infection. In: Moran AP, O'Morain CA, editors. Pathogenesis and host response in Helicobacter pylori infections. Bad Hamburg: Normed Verlag, p 148-157.
36. Kirchner T, Melber A, Fischbach W, Heilmann KL, Müller-Hermelink HK. 1990. Immunohistological patterns of the local immune response in Helicobacter pylori gastritis. In: Malfertheiner P, Ditschuneit H, editors. Helicobacter pylori, gastritis and peptic ulcer. Berlin: Springer-Verlag, p 213-222.
37. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. 1995a. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 87:1777-1780.
38. Kuipers EJ, Thijs JC, Festen HP. 1995b. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 2:59-69.
39. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, Festen HP, Meuwissen SG. 1995c. Long-term sequelae of Helicobacter pylori gastritis. Lancet 345:1525-1528.
40. Ma JY, Borch K, Sjostrand SE, Janzon L, Mardh S. 1994. Positive correlation between H,K-adenosine triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand J Gastroenterol 29:961-965.
41. Maaroos HI, Havu N, Sipponen P. 1998. Follow-up of Helicobacter pylori positive gastritis and argyrophil cells pattern during the natural course of gastric ulcer [see comments]. Helicobacter 3:39-44.
42. Maconi G, Lazzaroni M, Sangaletti O, Bargiggia S, Vago L, Porro GB. 1997. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer. Am J Gastroenterol 92:1844-1848.
43. Negrini R, Lisato L, Zanella I, Cavazzini L, Gullini S, Villanacci V, Poiesi C, Albertini A, Ghielmi S. 1991. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 101:437-445.
44. Negrini R, Savio A, Poiesi C, Appelmelk BJ, Buffoli F, Paterlini A, Cesari P, Graffeo M, Vaira D, Franzin G. 1996. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111:655-665.
45. Nomura A, Stemmermann GN, Chyou PH, Kalo I, Ferez PG, Blaser MJ. 1991. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132-1136.
46. Oberhuber G, Wuendisch T, Rapel S, Stolte M. 1998. Significant improvement of atrophy after eradication therapy in atrophic body gastritis. Path Res Pract 194:609-613.
47. Ogura K, Kanai F, Maeda S, Yoshida H, Ogura M, Lan KH, Hirota K, Kawabe T, Shiratori Y, Omata M. 1997. High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan. Gut 41:463-468.
48. Pan ZJ, van der Hulst RW, Feller M, Xiao SD, Tytgat GN, Dankert J, van der Ende A. 1997. Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol 35:1344-1347.
49. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich H, Sibley R. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127-1131.
50. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. 1997. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40:297-301.
51. Rudi J, Kolb C, Maiwald M, Kuck D, Sieg A, Galle PR, Stremmel W. 1998. Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol 36:944-948.
52. Sakagami T, Dixon M, O'Rourke J, Hewlett R, Alderuccio F, Vella J, Shimoyama T, Lee A. 1996. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut 39:639-648.
53. Saxena V, Asante M, Mendall MA, Neira N, Zaitoun AM, Northfield TC. 1998. Gastric parietal cell antibodies are associated with an altered distribution of Helicobacter pylori and increased body atrophy. Gut 42(Suppl. 1):A79.
54. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Saito Y, Munakata A. 1997. High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scand J Gastroenterol 32:465-468.
55. Sommer F, Faller G, Konturek P, Kirchner T, Hahn EG, Zeus J, Rollinghoff M, Lohoff M. 1998. Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun 66:5543-5546.
56. Steininger H, Faller G, Dewald E, Brabletz T, Jung A, Kirchner T. 1998. Apoptosis in chronic gastritis and its correlation with antigastric autoantibodies. Virchows Arch 433:13-18.
57. Stolte M, Baumann K, Bethke B, Ritter M, Lauer E, Eidt H. 1992. Active autoimmune gastritis without total atrophy of the glands. Z Gastroenterol 30:729-735.
58. Takata T, Fujimoto S, Anzai K, Shirotani T, Okada M, Sawae Y, Ono J. 1998. Analysis of the expression of CagA and VacA and the vacuolating activity in 167 isolates from patients with either peptic ulcers or non-ulcer dyspepsia. Am J Gastroenterol 93:30-34.
59. Tucci A, Biasco G, Paparo GF. 1997. Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis. N Engl J Med 336:957-958.
60. Uibo R, Vorobjova T, Metskula K, Kisand K, Wadstrom T, Kivik T. 1995. Association of Helicobacter pylori and gastric autoimmunity: a population-based study. Fems Immunol Med Microbiol 11:65-68.
61. Valle J, Kekki M, Sipponen P, Ihamaki T, Siurala M. 1996. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 31:546-550.
62. van der Hulst RW, van der Ende A, Dekker FW, Ten Kate FJ, Weel JF, Keller JJ, Kruizinga SP, Dankert J, Tytgat GN. 1997. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 113:25-30.
63. Warburton VJ, Everett S, Mapstone NP, Axon AT, Hawkey P, Dixon MF. 1998. Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol 51:55-61.
64. Warren JR, Marshall BJ. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273-1275.
65. Wirth HP, Yang M, Peek RM, Tham KT, Blaser MJ. 1997a. H. pylori Lewis expression: relationship to host Lewis phenotype, antibody response to Lewis antigens, and gastric histopathology. Gut 41: (Suppl. 1):A61.
66. Wirth HP, Yang M, Peek RM Jr, Tham KT, Blaser MJ. 1997b. Helicobacter pylori Lewis expression is related to the host Lewis phenotype. Gastroenterology 113:1091-1098.
67. Wotherspoon AC, Ortitz-Hidalgo C, Falzon MR, Isaacson PG. 1991. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175-1176.
68. Wyatt JI, Dixon MF. 1988. Chronic gastritis - a pathogenic approach. J Pathol 154:113-124.
69. Ye G, Barrera C, Fan X, Gourley WK, Crowe SE, Ernst PB, Reyes VE. 1997. Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells. J Clin Invest 99:1628-1636.